Evidence map›Paper›PMID 37908192›Full record

ArticleCancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology2023

Advancing Social and Environmental Research in Cancer Registries Using Geomasking for Address-Level Data.

Hari S Iyer, Xun Shi, Jaya M Satagopan, Iona Cheng, Charlotte Roscoe, Robert H McLaughlin, Antoinette M Stroup, Soko Setoguchi, Elisa V Bandera, Brenda Y Hernandez and 7 more

Open access · greenAbstract read
In one paragraph

Article in Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
1.3field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 6 citations in OpenAlex.

  1. Review
  2. Article
  3. Review
  4. Review
  5. Geospatial Science for the Environmental Epidemiology of Cancer in the Exposome Era.Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology · 2024
    Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

17 authors at 10 institutions in 2 countries.

Hari S IyerSection of Cancer Epidemiology and Health Outcomes, Rutgers Cancer Institute of New Jersey, New Brunswick, New Jersey.ORCID 0000-0002-7596-9049
Xun ShiDepartment of Geography, Dartmouth College, Hanover, New Hampshire.ORCID 0000-0002-7169-5175
Jaya M SatagopanDepartment of Biostatistics and Epidemiology, Rutgers School of Public Health, Piscataway, New Jersey.ORCID 0000-0001-6612-4856
Iona ChengDepartment of Epidemiology & Biostatistics, University of California San Francisco, San Francisco, California.ORCID 0000-0003-4132-2893
Charlotte RoscoeDivision of Population Sciences, Dana-Farber Cancer Institute, Boston, Massachusetts.ORCID 0000-0002-9169-6458
Robert H McLaughlinCancer Registry of Greater California, Public Health Institute, Oakland, California.ORCID 0000-0002-4997-6333
Antoinette M StroupSection of Cancer Epidemiology and Health Outcomes, Rutgers Cancer Institute of New Jersey, New Brunswick, New Jersey.ORCID 0000-0003-3341-4018
Soko SetoguchiRutgers University Institute for Health, Healthcare Policy, and Aging Research, the State University of New Jersey, New Brunswick, New Jersey.ORCID 0000-0002-1583-752X
Elisa V BanderaSection of Cancer Epidemiology and Health Outcomes, Rutgers Cancer Institute of New Jersey, New Brunswick, New Jersey.ORCID 0000-0002-8789-2755
Brenda Y HernandezHawai'i Tumor Registry, University of Hawai'i Cancer Center, Honolulu, Hawaii.ORCID 0000-0003-0132-4042
Jennifer A DohertyDepartment of Population Science, Huntsman Cancer Institute, University of Utah, Salt Lake City, Utah.ORCID 0000-0002-1454-8187
Mei-Chin HsiehLouisiana Tumor Registry and Epidemiology Program, School of Public Health at Louisiana State University Health Sciences Center, New Orleans, Louisiana.ORCID 0000-0001-7842-1225
Richard KnowltonMassachusetts Cancer Registry, Office of Data Management and Outcomes Assessment, Office of Population Health, Massachusetts Department of Public Health, Boston, Massachusetts.ORCID 0009-0007-4381-7677
Bo QinSection of Cancer Epidemiology and Health Outcomes, Rutgers Cancer Institute of New Jersey, New Brunswick, New Jersey.ORCID 0000-0003-2110-6050
Francine LadenDepartment of Environmental Health, Harvard T. H. Chan School of Public Health, Boston, Massachusetts.ORCID 0000-0002-2813-2174
Timothy R RebbeckDivision of Population Sciences, Dana-Farber Cancer Institute, Boston, Massachusetts.ORCID 0000-0002-4799-1900
Scarlett L GomezDepartment of Epidemiology & Biostatistics, University of California San Francisco, San Francisco, California.ORCID 0000-0002-5143-4867
Rutgers, The State University of New Jersey · USHarvard University · USUniversity of California, San Francisco · USCancer Center of Hawaii · USDana-Farber Cancer Institute · USDartmouth College · USHuntsman Cancer Institute · USLouisiana State University Health Sciences Center New Orleans · USMassachusetts Department of Public Health · USPublic Health Institute · US

Funding

Study of exposures and biomarkers in cancer epidemiologyR01CA197402 · NCI · SLOAN-KETTERING INST CAN RESEARCH · PI SATAGOPAN, JAYA M · 2016 to 2019
$1.6M
NCI NIH HHS R01 CA197402
6 · The paper itself

Abstract

Understanding the social and environmental causes of cancer in the United States, particularly in marginalized communities, is a major research priority. Population-based cancer registries are essential for advancing this research, given their nearly complete capture of incident cases within their catchment areas. Most registries limit the release of address-level geocodes linked to cancer outcomes to comply with state health departmental regulations. These policies ensure patient privacy, uphold data confidentiality, and enhance trust in research. However, these restrictions also limit the conduct of high-quality epidemiologic studies on social and environmental factors that may contribute to cancer burden. Geomasking refers to computational algorithms that distort locational data to attain a balance between effectively "masking" the original address location while faithfully maintaining the spatial structure in the data. We propose that the systematic deployment of scalable geomasking algorithms could accelerate research on social and environmental contributions across the cancer continuum by reducing measurement error bias while also protecting privacy. We encourage multidisciplinary teams of registry officials, geospatial analysts, cancer researchers, and others engaged in this form of research to evaluate and apply geomasking procedures based on feasibility of implementation, accuracy, and privacy protection to accelerate population-based research on social and environmental causes of cancer.

Indexed as

NeoplasmsPrivacyConfidentialityHumansRegistriesTrustUnited States

Identifiers

PMID37908192
PMCPMC12042738
OpenAlexW4388132813

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.